| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5902866 | Journal of Diabetes and its Complications | 2013 | 6 Pages |
Abstract
Treatment of type 2 diabetes with once-daily dapagliflozin 5 or 10Â mg is accompanied by a slightly increased risk of urinary tract infection. Infections were generally mild to moderate and clinically manageable. This analysis did not demonstrate a definitive dose relationship between glucosuria and urinary tract infection.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Kristina M. Johnsson, Agata Ptaszynska, Bridget Schmitz, Jennifer Sugg, Shamik J. Parikh, James F. List,